IDEAYA Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

IDEAYA Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $112.83 million for the year ending 2025.

  • IDEAYA Biosciences, Inc. showed an increase of +33.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), IDEAYA Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,792.7%.
  • Historical annual values: Fiscal year 2025: $112.83 million | Fiscal year 2024: $84.38 million | Fiscal year 2023: $157.02 million | Fiscal year 2022: $68.63 million | Fiscal year 2021: $92.05 million | Fiscal year 2020: $72.04 million | Fiscal year 2019: $34.07 million | Fiscal year 2018: $20.51 million | Fiscal year 2017: $5.96 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: